trending Market Intelligence /marketintelligence/en/news-insights/trending/cgmxfHrZUVnoj88ef4tErg2 content esgSubNav
In This List

Rhythm Pharmaceuticals prices IPO

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Rhythm Pharmaceuticals prices IPO

Rhythm Pharmaceuticals Inc. priced its IPO of 7,050,000 common shares at $17 apiece.

The company granted underwriters a 30-day option to buy up to an additional 1,057,500 common shares at the offering price.

The shares are scheduled to start trading Oct. 5 on the Nasdaq Global Market under the symbol RYTM.

The offering is expected to close Oct. 10, subject to customary closing conditions.

Morgan Stanley, BofA Merrill Lynch and Cowen are acting as lead book-running managers of the offering, with Needham & Co. as co-manager.